Breathing New Life into Pulmonary Disease Patients with Lipid-Based Inhalation Systems for Effective Lung Targeting
Time: 11:15 am
day: Conference Day One
Details:
- Tackling critical obstacles including drug stability during aerosolization, crossing mucosal barriers and precise cell-type targeting to maximize the potency of pulmonary delivery
- Designing an inhalation system with enhanced stability and reduced immunogenicity to improve patient outcomes with a safer therapeutic for pulmonary diseases
- Overcoming particle deposition and uneven therapeutic distribution in the respiratory tract to enhance the effectiveness of inhaled lung-targeted drugs
